trihexyphenidyl has been researched along with Tardive Dyskinesia in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Tardive Dyskinesia: Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bashir, HH | 1 |
| Jankovic, J | 1 |
1 review available for trihexyphenidyl and Tardive Dyskinesia
| Article | Year |
|---|---|
Treatment of Tardive Dyskinesia.
Topics: Antipsychotic Agents; Botulinum Toxins; Deep Brain Stimulation; Electroconvulsive Therapy; Humans; M | 2020 |